Compare Alcon AG (ALC) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs D Wave Quantum Inc — how do they compare? Alcon AG trades at $66.89 (market cap $32.69B), while D Wave Quantum Inc trades at $20.71 (market cap $7.80B). The key difference: Alcon AG is far larger — about 4.2× D Wave Quantum Inc's market cap, and Alcon AG pays a 0.54% dividend while D Wave Quantum Inc pays none. Which is the better fit depends on your goals.
| ALC | QBTS | |
|---|---|---|
Market Cap | $32.69B | $7.80B |
Sector | Health | Technology |
52-Week High | $92.22 | $44.78 |
52-Week Low | $62.02 | $12.98 |
Enterprise Value | $36.28B | $7.26B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
D-Wave Quantum (QBTS) trades at $22.56, up 0.11% on the day, amid a bearish technical signal from moving averages. The company reported a net loss of $355.06 million on $24.59 million revenue in 2025, with a negative net income margin of -2,957.23%. Recent positive developments include being named a Leader in the IDC MarketScape quantum computing assessment and securing a $1.5 million NSF grant.
Despite unanimous analyst buy ratings and a $39.86 consensus price target, significant risks include extreme cash burn, negative profitability, and the speculative nature of quantum computing commercialization. The stock's high P/S ratio of 619.05 reflects growth expectations but underscores valuation sensitivity to execution milestones.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
